Home / Market Reports / Service & Software / Global Biolayer Interferometry (BLI) Market Growth (Status and Outlook) 2024-2030

Global Biolayer Interferometry (BLI) Market Growth (Status and Outlook) 2024-2030

Global Biolayer Interferometry (BLI) Market Growth (Status and Outlook) 2024-2030

Product Code:1199250

Published Date: Jun 12,2024

Pages: 117

Region: Global

Category: Service & Software

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface. 
The global Biolayer Interferometry (BLI) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Biolayer Interferometry (BLI) Industry Forecast” looks at past sales and reviews total world Biolayer Interferometry (BLI) sales in 2022, providing a comprehensive analysis by region and market sector of projected Biolayer Interferometry (BLI) sales for 2023 through 2029. With Biolayer Interferometry (BLI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biolayer Interferometry (BLI) industry.

This Insight Report provides a comprehensive analysis of the global Biolayer Interferometry (BLI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biolayer Interferometry (BLI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biolayer Interferometry (BLI) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biolayer Interferometry (BLI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biolayer Interferometry (BLI).

United States market for Biolayer Interferometry (BLI) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Biolayer Interferometry (BLI) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Biolayer Interferometry (BLI) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Biolayer Interferometry (BLI) players cover Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Biolayer Interferometry (BLI) market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Affinity and Kinetic Analysis
    Drug and Antibody Screening
    Drug and Antibody Discovery
    Protein Quantification
    Others

Segmentation by Application:
    Pharmaceutical Industry
    Diagnostics
    Biotechnology
    Scientific Research
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Affinity and Kinetic Analysis
    Drug and Antibody Screening
    Drug and Antibody Discovery
    Protein Quantification
    Others

Segmentation by Application:
    Pharmaceutical Industry
    Diagnostics
    Biotechnology
    Scientific Research
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Ichor Life Sciences, Inc
    Creative BioMart
    GenScript
    ROCKLAND IMMUNOCHEMICALS, INC
    BPS Bioscience, Inc
    Creative Proteomics
    Creative Biostructure
    Profacgen
    Creative Biolabs
    Biocult
    KMD Bioscience Co., Ltd